Knowledge Hub :

All

Senolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of Ageing

Research

Senolytics and Microbiome Modifiers Two Quiet Levers Reshaping the Biology of Ageing

How senolytics and microbiome modifiers are reshaping ageing biology by targeting inflammation, senescence, and system-level decline.

Mrudula Kulkarni | Feb 12, 2026

Psychedelic-Assisted Therapies: How Science Is Re-Exploring A Controversial Class Of Medicines

Research

Psychedelic-Assisted Therapies: How Science Is Re-Exploring A Controversial Class Of Medicines

How psychedelic-assisted therapies are being re-explored to treat depression, PTSD, and addiction through science-led care.

Vaibhavi M. | Feb 12, 2026

Live Biotherapeutic Products: The Future of Microbiome-Based Medicine

Innovation

Live Biotherapeutic Products: The Future of Microbiome-Based Medicine

A deep dive into the clinical development, safety considerations, and commercial future of live biotherapeutic products.

Vaibhavi M. | Jan 27, 2026

Engineered Microbes for APIs

Research

Engineered Microbes for APIs

How engineered microbes are quietly reshaping API manufacturing through biology, fermentation, and smarter, more resilient pharma production.

Mrudula Kulkarni | Jan 27, 2026

How Granulation Bottlenecks Are Silently Eating Into Pharma Margins?

Innovation

How Granulation Bottlenecks Are Silently Eating Into Pharma Margins?

Granulation bottlenecks rarely cause failures, but they quietly reduce throughput, inflate costs, and erode margins in pharma manufacturing.

Mrudula Kulkarni | Jan 21, 2026

Ad
Advertisement
News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news

AllResearchInnovationMarket Trends

Pharma Shorts